ResearcherJohns Hopkins UniversityActive in the last 2 years
Bo Huang
Matched on ORCID iD 0000-0001-8476-1138; OpenAlex author ID A5063303316, A5100667605. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 34
2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA-LNP. Last author DOI 10.1038/s41423-026-01390-2↗
- Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. Last author DOI 10.1038/s41556-022-00857-4↗
- Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer. Co-author DOI 10.1016/j.pan.2021.03.015↗
- Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. Co-author DOI 10.1158/0008-5472.can-19-1523↗
Closest collaborators
The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yabo Zhou · 2 shared papers, 2022–2026 · strength 0.36
- Paper Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA… DOI 10.1038/s41423-026-01390-2↗
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4↗
- Jiadi Lv · 2 shared papers, 2022–2026 · strength 0.36
- Paper Gasdermin E-mediated lysosome-pore formation curbs pancreatic ductal adenocarcinoma via IFN-γ/IFN-β/TGF-β cocktail mRNA… DOI 10.1038/s41423-026-01390-2↗
- Paper Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. DOI 10.1038/s41556-022-00857-4↗
- Heng Zhang · 1 shared paper, 2026 · strength 0.23
- Zi Wang · 1 shared paper, 2026 · strength 0.23
- Jin Peng He · 2 shared papers, 2020–2021 · strength 0.19
- Michael Goggins · 2 shared papers, 2020–2021 · strength 0.19
- Nicholas Jason Roberts · 2 shared papers, 2020–2021 · strength 0.19
- Yuying Liu · 1 shared paper, 2022 · strength 0.13
- Wei‐Min Tong · 1 shared paper, 2022 · strength 0.13
- Cancan Zhou · 1 shared paper, 2021 · strength 0.12
- Nancy R. Porter · 1 shared paper, 2021 · strength 0.12
- Alison P. Klein · 1 shared paper, 2021 · strength 0.12
- Ralph H. Hruban MD · 1 shared paper, 2021 · strength 0.12
- Daniel A. Laheru · 1 shared paper, 2021 · strength 0.12
- Alina Hasanain · 1 shared paper, 2020 · strength 0.07
- Sandra Elisabeth Fischer · 1 shared paper, 2020 · strength 0.07
- Stefan Heinrich · 1 shared paper, 2020 · strength 0.07
- Kohei Fujikura · 1 shared paper, 2020 · strength 0.07
- Bernat Navarro-Serer · 1 shared paper, 2020 · strength 0.07
- Yea Ji Jeong · 1 shared paper, 2020 · strength 0.07
- Michael Johannes Pflüger · 1 shared paper, 2020 · strength 0.07
- Limin Xia · 1 shared paper, 2020 · strength 0.07
- Amer H. Zureikat · 1 shared paper, 2020 · strength 0.07
- Richard Andrew Burkhart · 1 shared paper, 2020 · strength 0.07
- Matthias M. Gaida · 1 shared paper, 2020 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.